Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Depreciation & Amortization (CF): 2013-2024

Historic Depreciation & Amortization (CF) for Soleno Therapeutics (SLNO) over the last 12 years, with Dec 2024 value amounting to $2.0 million.

  • Soleno Therapeutics' Depreciation & Amortization (CF) changed negligibly% to $490,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $2.0 million, marking a year-over-year decrease of 0.25%. This contributed to the annual value of $2.0 million for FY2024, which is 1.48% up from last year.
  • According to the latest figures from FY2024, Soleno Therapeutics' Depreciation & Amortization (CF) is $2.0 million, which was up 1.48% from $2.0 million recorded in FY2023.
  • Soleno Therapeutics' 5-year Depreciation & Amortization (CF) high stood at $2.0 million for FY2024, and its period low was $2.0 million during FY2020.
  • Moreover, its 3-year median value for Depreciation & Amortization (CF) was $2.0 million (2022), whereas its average is $2.0 million.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first fell by 0.31% in 2023, then increased by 1.48% in 2024.
  • Over the past 5 years, Soleno Therapeutics' Depreciation & Amortization (CF) (Yearly) stood at $2.0 million in 2020, then increased by 0.46% to $2.0 million in 2021, then increased by 0.05% to $2.0 million in 2022, then fell by 0.31% to $2.0 million in 2023, then grew by 1.48% to $2.0 million in 2024.